Ashley E Rubinstein1, Zhongxing Liao2, Adam D Melancon3, Michele Guindani4, David S Followill3, Ramesh C Tailor3, John D Hazle5, Laurence E Court6. 1. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 and The University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030. 2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. 3. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. 5. Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. 6. Departments of Radiation Physics and Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
Abstract
PURPOSE: Magnetic fields are known to alter radiation dose deposition. Before patients receive treatment using an MRI-linear accelerator (MRI-Linac), preclinical studies are needed to understand the biological consequences of magnetic-field-induced dose effects. In the present study, the authors sought to identify a beam energy and magnetic field strength combination suitable for preclinical murine experiments. METHODS: Magnetic field dose effects were simulated in a mouse lung phantom using various beam energies (225 kVp, 350 kVp, 662 keV [Cs-137], 2 MV, and 1.25 MeV [Co-60]) and magnetic field strengths (0.75, 1.5, and 3 T). The resulting dose distributions were compared with those in a simulated human lung phantom irradiated with a 6 or 8 MV beam and orthogonal 1.5 T magnetic field. RESULTS: In the human lung phantom, the authors observed a dose increase of 45% and 54% at the soft-tissue-to-lung interface and a dose decrease of 41% and 48% at the lung-to-soft-tissue interface for the 6 and 8 MV beams, respectively. In the mouse simulations, the magnetic fields had no measurable effect on the 225 or 350 kVp dose distribution. The dose increases with the Cs-137 beam for the 0.75, 1.5, and 3 T magnetic fields were 9%, 29%, and 42%, respectively. The dose decreases were 9%, 21%, and 37%. For the 2 MV beam, the dose increases were 16%, 33%, and 31% and the dose decreases were 9%, 19%, and 30%. For the Co-60 beam, the dose increases were 19%, 54%, and 44%, and the dose decreases were 19%, 42%, and 40%. CONCLUSIONS: The magnetic field dose effects in the mouse phantom using a Cs-137, 3 T combination or a Co-60, 1.5 or 3 T combination most closely resemble those in simulated human treatments with a 6 MV, 1.5 T MRI-Linac. The effects with a Co-60, 1.5 T combination most closely resemble those in simulated human treatments with an 8 MV, 1.5 T MRI-Linac.
PURPOSE: Magnetic fields are known to alter radiation dose deposition. Before patients receive treatment using an MRI-linear accelerator (MRI-Linac), preclinical studies are needed to understand the biological consequences of magnetic-field-induced dose effects. In the present study, the authors sought to identify a beam energy and magnetic field strength combination suitable for preclinical murine experiments. METHODS: Magnetic field dose effects were simulated in a mouse lung phantom using various beam energies (225 kVp, 350 kVp, 662 keV [Cs-137], 2 MV, and 1.25 MeV [Co-60]) and magnetic field strengths (0.75, 1.5, and 3 T). The resulting dose distributions were compared with those in a simulated human lung phantom irradiated with a 6 or 8 MV beam and orthogonal 1.5 T magnetic field. RESULTS: In the human lung phantom, the authors observed a dose increase of 45% and 54% at the soft-tissue-to-lung interface and a dose decrease of 41% and 48% at the lung-to-soft-tissue interface for the 6 and 8 MV beams, respectively. In the mouse simulations, the magnetic fields had no measurable effect on the 225 or 350 kVp dose distribution. The dose increases with the Cs-137 beam for the 0.75, 1.5, and 3 T magnetic fields were 9%, 29%, and 42%, respectively. The dose decreases were 9%, 21%, and 37%. For the 2 MV beam, the dose increases were 16%, 33%, and 31% and the dose decreases were 9%, 19%, and 30%. For the Co-60 beam, the dose increases were 19%, 54%, and 44%, and the dose decreases were 19%, 42%, and 40%. CONCLUSIONS: The magnetic field dose effects in the mouse phantom using a Cs-137, 3 T combination or a Co-60, 1.5 or 3 T combination most closely resemble those in simulated human treatments with a 6 MV, 1.5 T MRI-Linac. The effects with a Co-60, 1.5 T combination most closely resemble those in simulated human treatments with an 8 MV, 1.5 T MRI-Linac.
Authors: B W Raaymakers; J J W Lagendijk; J Overweg; J G M Kok; A J E Raaijmakers; E M Kerkhof; R W van der Put; I Meijsing; S P M Crijns; F Benedosso; M van Vulpen; C H W de Graaff; J Allen; K J Brown Journal: Phys Med Biol Date: 2009-05-19 Impact factor: 3.609
Authors: B G Fallone; B Murray; S Rathee; T Stanescu; S Steciw; S Vidakovic; E Blosser; D Tymofichuk Journal: Med Phys Date: 2009-06 Impact factor: 4.071
Authors: H Omar Wooten; Olga Green; Min Yang; Todd DeWees; Rojano Kashani; Jeff Olsen; Jeff Michalski; Deshan Yang; Kari Tanderup; Yanle Hu; H Harold Li; Sasa Mutic Journal: Int J Radiat Oncol Biol Phys Date: 2015-03-17 Impact factor: 7.038
Authors: Ashley E Rubinstein; Skylar Gay; Christine B Peterson; Charles V Kingsley; Ramesh C Tailor; Julianne M Pollard-Larkin; Adam D Melancon; David S Followill; Laurence E Court Journal: PLoS One Date: 2018-11-16 Impact factor: 3.240